In this webinar, Dr. Blumenthal will review why proactive evaluation and delableing of inaccurate antibiotic allergies is a key component of antibiotics stewardship and quality improvement.
Speaker:
Kimberly Blumenthal, MD, MSC
Co-Director, Rheumatology & Allergy Clinical Epidemiology Research Center, Mongan Institute, Massachusetts General Hospital
Director of Research, Drug and Vaccine Allergy Center, Massachusetts General Hospital
Associate Professor, Harvard Medical School
Kimberly Blumenthal, MD, MSc is an Allergist/Immunologist and clinical researcher at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School. She is the Co-Director of the Clinical Epidemiology Research Center and Director of Research in the Center for Drug and Vaccine Allergy. Dr. Blumenthal performs drug and vaccine allergy research that uses methods of epidemiology, informatics, economics, decision science, and implementation science. Her research has been funded by the National Institute of Health, Agency for Healthcare Research and Quality, and foundations, including the American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the risk management foundation of Harvard Medical School. Dr. Blumenthal is internationally recognized for identifying the morbidity and mortality associated with unverified penicillin allergies and creating innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in diverse patient settings. Dr. Blumenthal has authored more than 170 peer-reviewed publications including leading high-impact manuscripts to publication in journals such as NEJM, Lancet, JAMA, and the BMJ. Dr. Blumenthal graduated from Columbia University with a BA in Economics. She studied medicine at Yale University School of Medicine, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology. She completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in 2017.
This Advances webinar is a partnership with the American College of Asthma, Allergy, and Immunology. ACAAI offers CME’s for this webinar.
_______________________________________________________________________________________
ALLERGY & ASTHMA NETWORK
The mission of Allergy and Asthma Network is to end the needless death and suffering due to asthma, allergies and related conditions. We do this through outreach, education, advocacy and research. More than 24 million Americans -- including 6 million children -- have asthma. More than 50+ million live with allergies. Talk with your doctor about creating a management and treatment plan. We're working every day so that we may all breathe better together.
Allergy & Asthma Network specializes in making health information accurate and understandable to all. We bring the patient voice to healthcare and promote standards of care proven to work. Prevention, prompt diagnosis and treatment:
• helps reduce emergency healthcare visits;
• keeps children in school and adults at work;
• allows participation in sports and other activities of daily life.
More from the Allergy & Asthma Network:
Latest news articles: allergyasthmanetwork.org/news/
Asthma articles: allergyasthmanetwork.org/what...
Allergy articles: allergyasthmanetwork.org/alle...
Anaphylaxis articles: allergyasthmanetwork.org/anap...
Overlap conditions: allergyasthmanetwork.org/heal...